Search academic texts

Information × Registration Number 0206U004131, 0103U000781 , R & D reports Title The investigation of activated lymphocytes (LAK) antitumor affect under its interaction with autologous soft tissue sarcoma cells, chemioresistant to doxorubicin popup.stage_title Head Berezhnaya N.M., Registration Date 13-02-2006 Organization R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology popup.description2 The activity of nonactivated (LPK) and activated by IL-2 peripheral blood lymphocytes (LAK) of patients with soft tissue and epithelial tumors was investigation. It has been shown that antitumor activity of lAK to resistant tumors was higher than sensitive tumors and independent from they origin. Influence of low doses of DOX on tumor cells-lymphocytes interaction was studied too. DOX changes this interaction: some doses of DOX increased antitumor effect LAK of patients with soft tissue sarcoms and DOX influenced on effect LAK of patients with epithelial tumors was differently. Product Description popup.authors popup.nrat_date 2020-04-02 Close